Literature DB >> 32523926

Stress Cardiomyopathy in COVID-19 Disease.

Maria Cristina Pasqualetto1, Eleonora Secco1, Manuele Nizzetto1, Moreno Scevola1, Lorella Altafini1, Alberto Cester1, Fausto Rigo1.   

Abstract

Patients affected by COVID-19 pneumonia may develop stress cardiomyopathy, also known as Takotsubo syndrome (TTS), at different stages during the disease and with different degrees of left ventricular dysfunction. We describe three cases of TTS in COVID-19-positive patients with different clinical presentations and outcomes. One of them died, while in the other two coronary angiography confirmed the diagnosis but was postponed until after pneumonia resolution because of the risk of virus spread. LEARNING POINTS: An association between COVID-19 and cardiac involvement is highlighted.The incidence of Takotsubo syndrome has increased during this pandemic, possibly because it is caused by acute stress. © EFIM 2020.

Entities:  

Keywords:  COVID-19; Takotsubo syndrome; cardiomyopathy

Year:  2020        PMID: 32523926      PMCID: PMC7279910          DOI: 10.12890/2020_001718

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


INTRODUCTION

Takotsubo syndrome (TTS) is a stress cardiomyopathy induced by intense emotional or physical stress leading to rapid, severe, and usually reversible, cardiac dysfunction, and accounts for 1.8–2.2% of all acute coronary syndromes [. There are suggestions that TTS may be associated with COVID-19 [.

CASE DESCRIPTION

We describe three cases of stress cardiomyopathy in patients recently admitted to the Covid hospital in Dolo, near Venice in Italy, for severe acute respiratory disease syndrome due to COVID-19 infection. They all had a history of appropriately treated arterial hypertension or diabetes, and were in good clinical condition before hospitalization according to the Clinical Frailty Scale [ (Table 1). None of them had previous history of cardiovascular disease and had common symptoms of infection including fever, cough with dyspnoea and atypical chest pain during the 10 days before their attendance at the emergency department (ED).
Table 1

Clinical characteristics

Patient 1Patient 2Patient 3
Age, years848581
GenderMaleFemaleMale
Cardiovascular risk factorArterial hypertension, diabetesArterial hypertensionArterial hypertension, diabetes
The clinical frailty schemeVery fitManaging wellWell
OutcomesDischarged homeDeathDischarged home
Medical treatmentsAspirin, fondaparinux sc, nitroglycerin iv, metoprolol ivAspirin, clopidogrel, fondaparinux sc, inotropic support ivAspirin, fondaparinux sc, metoprolol iv
Oxygen supplementHF nasal cannulaMechanical ventilationHF nasal cannula
PA02/Fi02>300<100>300
Hs-cTn ng/ml70 >58 >60647 >610 >519596 >621 >458
NT Pro-BNP ng/ml737 >13811859>30001096 >12586
D-dimer ng/ml138112273340
CRP mg/l168,8 >35,2170,9 >125,1190,4 >114,4
Pro-calcitonin ng/ml0,35 >0,091,47 > 3,010,01 >0,07

CRP, C-reactive protein; HF, high flow; Hs-cTn, high sensitivity troponin T; iv, intravenous; sc, subcutaneous.

All three nasopharyngeal swabs taken in ED were positive for COVID-19. Blood samples were analysed for high-sensitivity troponin T (hs-cTn), NT-proBNP and D-dimer after patients were admitted and also if their clinical condition worsened or the electrocardiogram (EKG) showed changes. All three patients were promptly treated with antiviral drugs and hydroxychloroquine and a daily EKG was performed to check QT interval duration. The pulmonary CT scan in all three patients was positive for ground-glass opacities and bilateral consolidation in the lungs. All patients had high D-dimer values or clinical features indicating thromboembolic acute events but none had symptoms, EKG findings, hs-cTn values or echocardiographic results suggesting ischaemia. Because of evidence of hypercoagulation in COVID-19 patients, subcutaneous fondaparinux 2.5 mg was administered together with other treatment mandated by hospital protocol. Suspicion of a stress cardiomyopathy was based on EKG alterations characterized by diffuse negative T waves on precordial leads with QT interval prolongation (Fig. 1) and a typical echocardiographic pattern characterized by dyskinesia of the left ventricle apex (apical ballooning) and basal wall hypercontractility with systolic dysfunction (Figs. 2 and 3).
Figure 1

EKG of patient 1

Figure 2

End diastolic left ventricular volume

Figure 3

End systolic left ventricular volume with typical apical ballooning

The first patient was an 84-year-old man with a normal PaO2/FiO2 ratio, who was treated with high-flow oxygen therapy via a nasal cannula. During hospitalization, he had sudden worsening of dyspnoea and chest pain caused by a hypertensive crisis with a blood pressure (BP) reading of 220/100 mmHg. Nitroglycerin and intravenous metoprolol were promptly administered with progressive improvement of symptoms and normalization of BP. hs-cTn was high at 70 ng/ml but did not show a typical ischaemic increase. The EKG and ultrasound showed typical TTS with a global preserved left ventricular ejection fraction (EF) of 53%. Because of significant COVID-19 lung involvement, coronary angiography was postponed for a couple of weeks until pneumonia had completely resolved, to avoid possible cardiovascular complications and virus spread. Aspirin was started before coronary angiography, which was negative for significant coronary stenosis. The second patient was an 85-year-old woman who was admitted to the Covid department with fever and cough. She presented septic shock due to Pseudomonas aeruginosa infection 2 days later and was transferred to the Intensive Care Unit. She had progressive respiratory failure (PaO2/FiO2 <100) which required mechanical ventilation, but blood oxygen saturation levels did not improve. We therefore performed an EKG and an echocardiogram which were highly suspicious for TTS. The echocardiography showed a severe reduction in LVEF (30%). Despite ventilation in the prone position, the use of plasma expander and inotropic support, the patient developed rapid multiorgan failure and died within a few hours. The autopsy confirmed a normal coronary anatomy. The third patient was an 81-year-old man with a normal PaO2/FiO2 ratio who was supported with high-flow nasal cannula oxygen. Blood samples revealed high NT-proBNP levels and abnormal hs-cTn values but without an increase indicating ischaemia. EKG and echocardiography showed typical TTS alterations, with a moderately impaired LVEF (42%). Coronary angiography performed after pneumonia resolution was negative for significant coronary stenosis.

DISCUSSION

There are few reports of stress cardiomyopathy in the COVID-19 population. However, direct myocardial injury has been frequently described and attributed to myocarditis, hypoxaemia or underlying coronary artery disease. Coagulopathy and vascular endothelial dysfunction have also been highlighted as complications of COVID-19 infection [. Stress cardiomyopathy is usually triggered by extreme sympathetic stimulation with abnormal release of catecholamines and subsequent epicardial coronary spasm [. Various different mechanisms coexist in COVID-19 patients which may contribute to left ventricular dysfunction. This pandemic disease may induce stress manifesting as an increase in cases of stress cardiomyopathy. We would also like to emphasize that urgent coronary angiography in acute COVID-19 pneumonia could put the patient and the cardiologist at risk due to virus spread. In light of the possibility that COVID-19 patients may have acute coronary syndrome, we should maintain suspicion of stress cardiomyopathy and postpone invasive examination until after complete recovery from COVID-19 pneumonia.
  6 in total

Review 1.  Stress cardiomyopathy: aetiology and management.

Authors:  Radhakrishnan Ramaraj
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

2.  A global clinical measure of fitness and frailty in elderly people.

Authors:  Kenneth Rockwood; Xiaowei Song; Chris MacKnight; Howard Bergman; David B Hogan; Ian McDowell; Arnold Mitnitski
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

3.  International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Authors:  Jelena-Rima Ghadri; Ilan Shor Wittstein; Abhiram Prasad; Scott Sharkey; Keigo Dote; Yoshihiro John Akashi; Victoria Lucia Cammann; Filippo Crea; Leonarda Galiuto; Walter Desmet; Tetsuro Yoshida; Roberto Manfredini; Ingo Eitel; Masami Kosuge; Holger M Nef; Abhishek Deshmukh; Amir Lerman; Eduardo Bossone; Rodolfo Citro; Takashi Ueyama; Domenico Corrado; Satoshi Kurisu; Frank Ruschitzka; David Winchester; Alexander R Lyon; Elmir Omerovic; Jeroen J Bax; Patrick Meimoun; Guiseppe Tarantini; Charanjit Rihal; Shams Y-Hassan; Federico Migliore; John D Horowitz; Hiroaki Shimokawa; Thomas Felix Lüscher; Christian Templin
Journal:  Eur Heart J       Date:  2018-06-07       Impact factor: 29.983

4.  Typical takotsubo syndrome triggered by SARS-CoV-2 infection.

Authors:  Philippe Meyer; Sophie Degrauwe; Christian Van Delden; Jelena-Rima Ghadri; Christian Templin
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

5.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

6.  Takotsubo Syndrome Associated with COVID-19.

Authors:  Elena Roca; Carlo Lombardi; Marco Campana; Oscar Vivaldi; Barbara Bigni; Bruno Bertozzi; Giovanni Passalacqua
Journal:  Eur J Case Rep Intern Med       Date:  2020-04-21
  6 in total
  14 in total

Review 1.  The extended autonomic system, dyshomeostasis, and COVID-19.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2020-07-22       Impact factor: 4.435

Review 2.  Management principles in patients with COVID-19: perspectives from a growing global experience with emphasis on cardiovascular surveillance.

Authors:  Gruschen R Veldtman; Enrico Storti; Mario Pirisi; Asad Roomi; Fadl Elmula M Fadl-Elmula; Olga Vriz; Sabahat Bokhari; Naser Ammash; Yezan Salam; Guang Zong Liu; Stefano Spinelli; Greta Barbieri; Shahrukh Hashmi
Journal:  Open Heart       Date:  2020-11

Review 3.  Takotsubo Syndrome and COVID-19: Associations and Implications.

Authors:  Rohan M Shah; Morish Shah; Sareena Shah; Angela Li; Sandeep Jauhar
Journal:  Curr Probl Cardiol       Date:  2020-12-11       Impact factor: 5.200

Review 4.  Takotsubo Syndrome a Rare Entity in COVID-19: a Systemic Review-Focus on Biomarkers, Imaging, Treatment, and Outcome.

Authors:  Kamal Sharma; Hardik D Desai; Jaimini V Patoliya; Dhigishaba M Jadeja; Dhruv Gadhiya
Journal:  SN Compr Clin Med       Date:  2021-01-11

5.  COVID-19 and Cardiomyopathy: A Systematic Review.

Authors:  Fatemeh Omidi; Bahareh Hajikhani; Seyyedeh Neda Kazemi; Ardeshir Tajbakhsh; Sajedeh Riazi; Mehdi Mirsaeidi; Ali Ansari; Masoud Ghanbari Boroujeni; Farima Khalili; Sara Hadadi; Mohammad Javad Nasiri
Journal:  Front Cardiovasc Med       Date:  2021-06-17

Review 6.  Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.

Authors:  Maya Guglin; Kareem Ballut; Onyedika Ilonze; Mark Jones; Roopa Rao
Journal:  Heart Fail Rev       Date:  2021-07-02       Impact factor: 4.654

Review 7.  Sympathetic activation: a potential link between comorbidities and COVID-19.

Authors:  Andrea Porzionato; Aron Emmi; Silvia Barbon; Rafael Boscolo-Berto; Carla Stecco; Elena Stocco; Veronica Macchi; Raffaele De Caro
Journal:  FEBS J       Date:  2020-08-01       Impact factor: 5.542

Review 8.  Characteristics and outcome of patients with COVID-19 complicated by Takotsubo cardiomyopathy: case series with literature review.

Authors:  Shruti Hegde; Rizwan Khan; Magdi Zordok; Michael Maysky
Journal:  Open Heart       Date:  2020-10

9.  Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials.

Authors:  Toshiki Kuno; Hiroki Ueyama; Hisato Takagi; John Fox; Sripal Bangalore
Journal:  Cardiovasc Revasc Med       Date:  2020-08-01

Review 10.  SARS-CoV-2 triggered Takotsubo in 38 patients.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  J Med Virol       Date:  2020-10-30       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.